The opening post describes the usual case. This is about the unusual one.
Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before ordering is prudent.
This is the sort of thing that ought to be settled and apparently is not.
This follows post #11 rather than contradicting it.
The version of Availability that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Post #15 describes the usual case. This is about the unusual one.
Regional stock in your own country removes the border question entirely, which is the reason it changes the calculation rather than just the timing.
I would put the burden of proof on the interesting explanation, not the dull one.
Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position.
The short answer was in the first line; everything after is the working.
No notes. Posting so the count is not one.
Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before ordering is prudent.
Something worth flagging about Availability: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a coincidence.
Read the full topic (46 posts)
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Cross-border purchase within the EU: the actual rules
Cross-border purchase within the EU: the actual rules Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers on cross-border…
|
+6 | 10 | 41k | 11mo |
|
Revisiting: Language barriers in accessing a prescription abroad
Posting this under the heading it deserves: Revisiting: Language barriers in accessing a prescription abroad Everything below is what sits behind that. Asking about Language barriers in accessing on behalf of…
|
+131 | 148 | 28k | 5mo |
|
About the International category
Country-by-country availability and legality, dated because it changes constantly. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
|
+6 | 11 | 240 | 22mo |
|
Prescription portability between countries — the long version
On the subject in the title: Prescription portability between countries — the long version Working notes rather than a conclusion. A narrow question about Prescription portability between countries,…
|
2 | 182 | 21h | |
|
What changed in 2026, by region
What changed in 2026, by region — that is the question, and I have not found it answered plainly anywhere I have looked. Documenting an access outcome, dated, because everything in this category expires. As…
|
+110 | 122 | 1.4k | 18mo |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Canadian access and provincial variation
Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Trying to establish the boundary conditions on canadian access and provincial…
|
+74 | 80 | 7.7k | 18mo |
|
Cross-border purchase rules within the EU
On the subject in the title: Cross-border purchase rules within the EU Working notes rather than a conclusion. The question about cross-border purchase rules within that I actually want answered is the second…
|
+45 | 49 | 15k | 8mo |
|
Coming back to: Preparing for an appointment: one page, three questions
Preparing for an appointment: one page, three questions — setting out what I have, and where I think it stops being reliable. A question about how to describe something to a clinician rather than about the…
|
+51 | 56 | 1.4k | 2d |
|
Coming back to: Research-use-only labelling: what it means and what it does not
Research-use-only labelling: what it means and what it does not — setting out what I have, and where I think it stops being reliable. A labelling question, and I would like the answer to be about what the…
|
+45 | 50 | 39k | 20mo |
|
Prescription requirements and telehealth models — a second dataset
On the subject in the title: Prescription requirements and telehealth models — a second dataset Working notes rather than a conclusion. Posting a small dataset on Prescription requirements and telehealth…
|
+87 | 94 | 1.1k | 21d |